Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 December 2022 | Story Gerda-Marié van Rooyen | Photo Supplied
Crystal-Donna Roberts
Crystal-Donna Roberts is a multifaceted lady. She appears regularly in soaps and is now a published author too. Speurder Sammi, an Afrikaans book written for early teens, explores themes such as anxiety, trauma, and pain.

She loved mysteries from a young age. Growing up, Crystal- Donna Roberts was fond of Columbo and Murder she wrote. Roberts, who graduated with a BA Drama and Theatre Arts in 2005, says she had always liked the tricky puzzles Scooby-Doo and Nancy Drew had to solve. She eagerly joined them on their missions page by page. Being an actress and having a busy schedule in front of cameras, Roberts actively decided to put time aside last year to write while participating in the Jakes Gerwel mentorship programme for upcoming authors. A lifelong dream came true when she wrote her debut novel, Speurder Sammi: Die blou steen (Detective Sammi: The blue stone). Tafelberg published her mystery-based story, which Roberts launched in September.

“Sammi is a teenager who lives with her artist aunt Valerie. The duo went on holiday visiting Oumie and Dedda in the Northern Cape. Although Sammi will miss her friends, April and Lerato, she is looking forward to a change of scenery. It will also distract her mind from the anticipation of waiting for acceptance at an art school she fancies. However, rural towns are full of surprises – and chancers.”

“There are teenage memories we seldom forget. The memory of growing pains is still vivid in my mind. I recall it and draw inspiration from it.”

Roberts doesn’t have set rituals when she writes. “I allow myself to do what my body and soul likes. Sometimes this means simply sitting down and enjoying a cup of tea.” Looking back on her fellowship, she discovered her love for creating new worlds and allowing the story to develop a storyline of its own. “I’ve learned I still have a lot to learn – this excites me. I also learned the importance of deadlines, even though they are scary.”

The former UFS student says she chose the Northern Cape as the setting for her story as it is one of the most beautiful parts of our country. “It is one of the prettiest parts of our country. I wanted my character to explore new horizons, but to remain between her loved ones when she goes through her healing and strengthening process.” Although Roberts is determined to write her second book, the details are still unknown. In the meantime, she enjoys reading Walter Russel’s The Secret of Light. She draws inspiration from Andrew Davidson’s The Gargoyle. “Apart from the story that deeply resonates with me, I can appreciate the detail in the story and Davidson’s writing style.”

To enquire about stockists selling Speurder Sammi, visit www.nb.co.za.


Presenter and television, theatre and film actress, Roberts is currently starring in kykNET’s drama series, Fraksie. She is also known for her roles in 7de Laan, Getroud Met Rugby, Montana, Vallei van Sluiers, Krotoa, and The Endless River.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept